financetom
Market
financetom
/
Market
/
This analyst recommends buying Wipro, Metropolis Healthcare, Biocon — here’s why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This analyst recommends buying Wipro, Metropolis Healthcare, Biocon — here’s why
Jul 17, 2023 3:16 AM

As the trading week kicks off, Jay Thakkar, Head of Alternate Research at Sharekhan, is here with his stock recommendations for Monday's trading session. Thakkar, known for his keen insights into the market, has identified three stocks that he believes hold great potential for traders and investors.

Share Market Live

NSE

Jay Thakkar is bullish on Wipro, the stock has caught his attention as the momentum has shifted into a buy mode on both daily and weekly charts.

Thakkar suggests considering a "Buy" position for Wipro, with the short-term target set at Rs 450. Moreover, he highlights a crucial support level at Rs 406 on the lower side, indicating a favorable risk-reward ratio for traders.

Over the past month, Wipro's shares have witnessed an impressive gain of more than 11 percent adding to the positive sentiment surrounding the stock.

The second stock that Thakkar recommends is Metropolis Healthcare, a leading diagnostic company. According to his analysis, the stock has recently provided a breakout from a downtrend line resistance, indicating a potential shift in its trend.

Thakkar advises investors to consider a "Buy" position on Metropolis Healthcare at the current market price of Rs 1,482. He sets the near-term target range between Rs 1,570 and Rs 1,650.

To mitigate potential risks, he identifies a critical support level at Rs 1,440. As long as the stock holds above this level, the bullish sentiment remains intact. Over the last month, Metropolis Healthcare has shown an upward movement of more than 7 percent.

The final recommendation from Jay Thakkar is Biocon, a prominent player in the pharmaceutical industry. Given the positive performance of the pharma and IT sectors, Biocon has drawn his attention as it trades around the levels of Rs 267.

Thakkar suggests a "Buy" position on Biocon, setting the target price at Rs 295. This implies a potential gain of approximately 10 percent from the current levels. To manage downside risks, he advises placing a stop-loss at Rs 256.

Over the last month, Biocon's stock has shown notable growth, with a gain of more than 8 percent.

Disclaimer

: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Follow our live blog for more stock market updates

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TREASURIES-Yields rise as traders wait on inflation data
TREASURIES-Yields rise as traders wait on inflation data
Dec 9, 2024
NEW YORK, Dec 9 (Reuters) - U.S. Treasury yields rose on Monday as traders waited on key inflation data due this week to see whether stubbornly high price pressures could derail expectations for a Federal Reserve interest rate cut next week. The Fed is widely expected to cut rates by 25 basis points at the conclusion of its Dec. 17-18...
US wholesale inventories rebound marginally in October
US wholesale inventories rebound marginally in October
Dec 9, 2024
WASHINGTON (Reuters) - U.S. wholesale inventories rebounded moderately in October amid a small rise in stocks of long-lasting manufactured goods. The Commerce Department's Census Bureau said on Monday that wholesale inventories increased 0.2% as estimated last month. Stocks at wholesalers fell 0.2% in September. Economists polled by Reuters had expected that the gain in inventories, a key part of gross...
US wholesale inventories rebound marginally in October
US wholesale inventories rebound marginally in October
Dec 9, 2024
WASHINGTON, Dec 9 (Reuters) - U.S. wholesale inventories rebounded moderately in October amid a small rise in stocks of long-lasting manufactured goods. The Commerce Department's Census Bureau said on Monday that wholesale inventories increased 0.2% as estimated last month. Stocks at wholesalers fell 0.2% in September. Economists polled by Reuters had expected that the gain in inventories, a key part...
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
Dec 9, 2024
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 44,562.45 while the NASDAQ fell 0.68% to 19,724.61. The S&P 500 also fell, dropping, 0.51% to 6,059.08. Check This Out: Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday Leading...
Copyright 2023-2026 - www.financetom.com All Rights Reserved